These observations, together with the reported strong negative correlation between the expression of ZEB1 and ESRP1 in the lung, breast and pancreatic cancer patient samples (Preca et al., 2015), suggest that the ZEB1-ESRP1 axis is active across multiple cancer types (Fig. 2c). Here, ZEB1 is linked to pancreatic neoplasm.